Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Our commitment is to support your weight loss journey with safe, effective injections and attentive medical guidance
Article July 2026 Article July 2026 On-demand Webinar 16 July 2026
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alstrm syndrome: phase 3 trial design
Dec 1992;44(6):1013-1032
Mechanism of Action: GHS-R1a Agonist Ipamorelin exerts its effects through selective agonism of the growth hormone secretagogue receptor type 1a (GHS-R1a) , also known as the ghrelin receptor
Contact the prescribing clinician, who can evaluate the degree of abnormality, symptoms, previous results, other medications, and whether repeat testing or additional evaluation is needed
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
